HR tech firm Rippling raises new funding at $16.8 billion valuation, no IPO plans
Reuters· 2026-05-09 17:02AI Processing
Core Insights - Rippling, an HR software startup, raised $450 million in Series G funding, achieving a valuation of $16.8 billion, focusing on global revenue growth over immediate profitability [1][4][5] Funding and Valuation - The funding round included participation from notable investors such as Y Combinator, Elad Gil, Sands Capital, GIC, and Goldman Sachs Growth [2] - The new valuation of $16.8 billion marks an increase from the previous valuation of $13.5 billion in early 2024 [4] Employee Equity and IPO Plans - Rippling plans to repurchase up to $200 million of equity from current and former employees through a tender offer, which may become an annual event [2][3] - The CEO stated that the company does not have immediate plans for an IPO, emphasizing the need for profitability before considering going public [4][6] Business Performance and Strategy - Rippling has surpassed $100 million in annual recurring revenue and serves over 20,000 customers with a suite of more than 20 products [5] - The company is prioritizing growth over profitability, indicating a strategic choice to expand rapidly rather than slow down for immediate profit [6] Legal Challenges - Rippling is involved in ongoing legal disputes with competitor Deel, including allegations of corporate espionage, which have raised questions about competitive practices in the tech industry [7][8]
Can MP Materials Scale Magnet Production to Meet Demand?
ZACKS· 2026-04-16 16:01
Core Insights - MP Materials is strategically moving downstream into high-value rare earth magnet manufacturing, with its Fort Worth, TX facility serving as the production hub and engineering headquarters [1] Group 1: Facility Development and Operations - Construction of the Independence Facility began in February 2022, marking the first fully integrated rare earth metal, alloy, and magnet manufacturing operation in the U.S. [2] - The facility converts NdPr oxide from Mountain Pass into permanent magnets and precursor products, with integrated capabilities for magnet recycling [2] - In 2024, the company commissioned electrowinning capabilities to produce NdPr metal and added strip casting capabilities in 2025 for NdFeB alloy flake production [3] Group 2: Revenue Generation and Financial Performance - The Magnetics segment began generating revenues in Q1 2025, with $5.2 million from sales to General Motors, contributing $493 million to segment adjusted EBITDA [4] - Quarterly revenues increased to $19.9 million in Q2, $21.9 million in Q3, and $19.9 million in Q4 of 2025 [4] - For the full year 2025, the Magnetics segment generated $66.9 million in revenues, accounting for approximately 30% of total company revenues, and delivered $26.4 million in adjusted EBITDA [5] Group 3: Strategic Partnerships and Future Plans - In July 2025, MP Materials entered a long-term supply agreement with Apple for magnet development and recycling capabilities [6] - The company is expanding the Independence Facility's annual capacity to 3,000 MTs and plans to construct the 10X Facility, expected to produce 7,000 MTs annually starting in 2028 [7] - These efforts will increase overall U.S. rare earth magnet production capacity to an estimated 10,000 MTs per year, enhancing supply-chain resilience [8] Group 4: Market Performance and Valuation - MP Materials' shares have increased by 125.8% over the past year, outperforming the industry's growth of 58.5% [9] - The Magnetics segment's revenues in 2025 were $66.9 million, representing about 30% of total sales, with long-term supply agreements secured with General Motors and Apple [10] - The Zacks Consensus Estimate for MP Materials' 2026 earnings is 19 cents per share, improving from a loss of 24 cents in 2025, with a projected estimate of $1.12 per share for 2027 [11]
Analyst Report: Wells Fargo & Co
Yahoo Finance· 2026-04-15 10:50
Sign in Sign in to access your portfolio ...
Canada’s Mr Mikes signs five-unit franchise deal in Ontario
Yahoo Finance· 2026-04-15 09:37
Core Insights - Mr Mikes Restaurants has signed a development agreement for five new restaurants in Ontario, Canada, as part of its ongoing expansion strategy [1][5] - The agreement was made with a well-established multi-unit restaurant operator, indicating confidence in the brand's growth potential [1][2] - The company aims to reach a target of 100 locations nationwide, currently operating 50 restaurants across various provinces [4][5] Expansion Strategy - The five-store agreement is seen as a significant milestone for Mr Mikes as it expands deeper into Ontario and prepares for further growth in Atlantic Canada [2][3] - Site selection in Ontario is already underway, reflecting the brand's proactive approach to expansion [3] Franchise Support Framework - Mr Mikes emphasizes its franchise support framework, which includes recruitment, site selection guidance, operational training, marketing assistance, and ongoing business development services [3][4] - The company believes that the commitment from seasoned operators to multi-location deals demonstrates the scalability and sustainability of the Mr Mikes model [4]
BIZD’s 25 BDC holdings mask growing weakness in its top income sources
Yahoo Finance· 2026-04-14 11:15
Core Viewpoint - The VanEck BDC Income ETF (BIZD) aims to provide income through a diversified portfolio of Business Development Companies (BDCs), but the current dividend safety across its top holdings is inconsistent, warranting careful evaluation before assuming the sustainability of its yield [1][6]. Group 1: Income Generation Mechanism - BDCs are specialized lenders that provide credit to middle-market companies unable to access public debt markets, and they are required by law to distribute at least 90% of taxable income to shareholders, resulting in high yields [2]. - BIZD collects dividends from over 25 individual BDCs, with Ares Capital being the largest holding at 13.1%, followed by Blue Owl Capital Corp at 7.9%, Main Street Capital at 6.7%, Golub Capital BDC at 2.9%, and FS KKR Capital at 2.7% [2]. Group 2: Impact of Federal Reserve Rates - The income generated by BDCs is primarily floating-rate, meaning that when the Federal Reserve cuts rates, portfolio yields decrease. The Fed has reduced rates three times since September 2025, lowering the federal funds rate from 4.5% to 3.75%, which poses a significant challenge for BIZD's holdings [3]. Group 3: Performance of Key Holdings - Ares Capital is the most critical position in BIZD, maintaining a core EPS of $0.50 per share throughout 2025, which comfortably covers its $0.48 quarterly dividend. Net investment income per share ranged from $0.48 to $0.54, although weighted average portfolio yields fell from 11.1% to 10.3% [4]. - Despite Ares Capital's stability, two major holdings in BIZD have already cut their dividends in 2026, indicating uneven dividend safety across the portfolio [6].
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losess in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AQST
TMX Newsfile· 2026-04-12 19:25
Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Aquestive Therapeutics, Inc. during the specified class period of the upcoming lead plaintiff deadline on May 4, 2026 [1]. Group 1: Class Action Details - Investors who bought Aquestive securities between June 16, 2025, and January 8, 2026, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by visiting the provided link or contacting the firm directly [3][6]. - The lawsuit alleges that the defendants made false or misleading statements regarding the New Drug Application for Anaphylm and concealed significant human factors related to its sublingual film [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms issuing notices may lack the necessary experience [4]. - Rosen Law Firm has a strong history in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its performance in securities class action settlements, ranking highly in the industry since 2013 [4].
ROSEN, A LEADING NATIONAL FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
TMX Newsfile· 2026-04-12 19:01
Core Viewpoint - Rosen Law Firm is reminding investors who purchased Aldeyra Therapeutics, Inc. securities between November 3, 2023, and March 16, 2026, of the May 29, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Aldeyra securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by visiting the provided link or contacting the firm directly [3][6]. - The deadline to move the Court to serve as lead plaintiff is May 29, 2026, and a lead plaintiff acts on behalf of other class members [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]. Group 3: Case Allegations - The lawsuit alleges that defendants made false and misleading statements regarding the clinical trials of reproxalap, an Aldeyra drug candidate, leading to unreliable positive findings [5]. - It is claimed that the inconsistency of trial results rendered the defendants' statements about Aldeyra's business and prospects materially false and misleading [5]. - The lawsuit asserts that when the true details were revealed, investors suffered damages as a result [5].
Catalyst Alert: Alphabet Just Made Broadcom's Stock a Must-Buy
The Motley Fool· 2026-04-12 18:11
Core Viewpoint - Broadcom's extended partnership with Alphabet for Tensor Processing Units (TPUs) significantly enhances its growth outlook and alleviates previous bearish concerns regarding its stock [1][2]. Partnership Details - The renewed agreement between Broadcom and Alphabet solidifies their long-standing collaboration on TPUs, which has been a major growth driver for both companies [2][4]. - Concerns that Alphabet might shift TPU production in-house or to a cheaper vendor have been mitigated by this deal, as Broadcom's ASIC platform is comprehensive and sticky [4]. Growth Potential - The partnership expansion includes a collaboration with Anthropic, granting access to 3.5 gigawatts of TPUs starting in 2027, with a $21 billion order for TPUs from Anthropic this year [5]. - Broadcom previously projected $100 billion in custom AI chip revenue by fiscal 2027, and this announcement suggests that this estimate may be conservative [7]. Financial Metrics - Broadcom's TPU sales are expected to maintain gross margins similar to its semiconductor business, further supporting its growth narrative [7]. - The company is gaining new ASIC customers, including OpenAI, which indicates a shift away from reliance on Nvidia's GPUs [7]. Investment Outlook - With the two major bearish arguments—lower margins and potential loss of TPU business—debunked, Broadcom is positioned as a strong growth stock [8].
APO FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Apollo Global Management, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - APO
TMX Newsfile· 2026-04-12 17:50
Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Apollo Global Management, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Apollo Global securities between May 10, 2021, and February 21, 2026, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by May 1, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]. Group 3: Case Allegations - The lawsuit alleges that Apollo Global's leadership made false and misleading statements regarding their business relationship with Jeffrey Epstein, claiming they had never done business with him, which was untrue [5]. - The entanglement of Apollo Global's leaders with Epstein is said to have harmed the company's reputation, leading to materially false and misleading statements about its business and operations [5]. - The lawsuit claims that when the true details emerged, investors suffered damages as a result of these misleading statements [5].
Tesla's Big Rig Could Be a Big Success and Still Disappoint
The Motley Fool· 2026-04-12 17:01
Core Insights - Tesla's electric Semi truck aims to disrupt the Class 8 truck market, contrasting with the less successful Cybertruck initiative [1][4] - There are concerns that expectations for the Semi may be too high, potentially leading to disappointment among investors even if the truck is successful [2][11] Production and Market Potential - Tesla's Semi production is ramping up after delays, with a target of producing between 5,000 and 15,000 units by 2026 [5] - The annual production capacity at Tesla's Nevada factory is projected to be 50,000 trucks, but initial sales volume may still disappoint investors [9] Pricing and Performance - The starting price of Tesla's Semi is approximately $300,000, nearly double that of comparable diesel trucks, which presents a challenge in terms of closing the gap with fuel savings and maintenance costs [6] - Pilot testing has shown promising results, with reports of over 400 miles achieved on runs, and weight reductions have allowed the Semi to achieve payload parity with diesel trucks [7] Market Context - The Class 8 truck market totaled 208,000 units in 2025, and capturing a small market share would be a significant achievement for Tesla [10] - If Tesla's Semi can reach annual sales of 10,000 units by the end of the decade, it would be considered a substantial success [10] Investor Sentiment - Investors are advised to temper expectations regarding near-term sales figures, as the success of Tesla's Semi should not be solely judged by initial volume [11]